Eli Lilly and Co (NYSE:LLY)
| 154.82 Delayed Data As of Aug 04 |  -0.03 / -0.02%Today’s Change | 101.36 Today|||52-Week Range 170.75 | +17.80% Year-to-Date |
Latest LLY News | Press Releases
Today’s Trading
| Previous close | 154.85 |
| Today’s open | 153.58 |
| Day’s range | 153.18 - 156.01 |
| Volume | 65 |
| Average volume (3 months) | 3,691,080 |
| Market cap | $143.7B |
Data as of 3:59pm ET, 08/04/2020
Growth & Valuation
| Earnings growth (last year) | +58.64% |
| Earnings growth (this year) | +17.63% |
| Earnings growth (next 5 years) | +14.90% |
| Revenue growth (last year) | -9.11% |
| P/E ratio | 25.3 |
| Price/Sales | 5.51 |
| Price/Book | 55.20 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AZNAstraZeneca | -0.02 | -0.03% |
| BMYBristol-Myers Squibb | +0.01 | +0.02% |
| ABBVAbbVie | -0.04 | -0.04% |
| SNYSanofi | -1.42 | -2.67% |
Data as of 5:21pm ET, 08/04/2020
Financials
| Next reporting date | October 27, 2020 |
| EPS forecast (this quarter) | $1.71 |
| Annual revenue (last year) | $22.3B |
| Annual profit (last year) | $4.6B |
| Net profit margin | 20.78% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Indianapolis, Indiana |
Forecasts
